Back to Search
Start Over
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
- Source :
- Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p132-134, 3p
- Publication Year :
- 2019
- Subjects :
- STOCK ownership
Subjects
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 37
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 137029545
- Full Text :
- https://doi.org/10.1002/hon.93_2629